Results 31 to 40 of about 766,404 (301)

TREATMENT ALGORITHMS IN TREATMENT-RESISTANT DEPRESSION

open access: yesPsychiatric Clinics of North America, 1996
When faced with a patient having treatment-resistant depression, it is essential to maintain a systematic approach to diagnosis and treatment: 1. Consider the presence of comorbid medical or psychiatric illness that may contribute to or cause the refractory state 2. Determine the affective subtype of depression (e.g., unipolar vs. phenotypic variant of
J D, Amsterdam, M, Hornig-Rohan
openaire   +2 more sources

Modeling treatment-resistant depression [PDF]

open access: yesNeuropharmacology, 2011
Depression is a polygenic and highly complex psychiatric disorder that is currently a major burden on society. Depression is highly heterogeneous in presentation and frequently exhibits high comorbidity with other psychiatric and somatic disorders. Commonly used treatments, such as selective serotonin reuptake inhibitors (SSRIs), are not ideal since ...
Benjamin Adam, Samuels   +8 more
openaire   +2 more sources

TREATMENT RESISTANT DEPRESSION

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Although it is reported that 25% of depressive patients remain resistant to antidepressant treatments, treatment resistant depression (TRD) has not yet been defined clearly.
Olcay YAZICI
doaj  

Esketamine for treatment‑resistant depression: A review of clinical evidence (Review)

open access: yesExperimental and Therapeutic Medicine, 2023
Treatment-resistant depression (TRD) is a challenge for psychiatrists, even after more than seven decades since the first antidepressants were used in clinical practice.
O. Vasiliu
semanticscholar   +1 more source

Rethinking treatment-resistant depression to quasi-tenacious depression

open access: yesEuropean Psychiatry, 2023
With almost one-third of patients with major depression not adequately responsive to treatments, the management of treatment-resistant depression (TRD) has continued to be challenging.
Shokouh Arjmand   +2 more
doaj   +1 more source

Nationwide consensus on the clinical management of treatment-resistant depression in Italy: a Delphi panel

open access: yesAnnals of General Psychiatry, 2023
Background Treatment-resistant depression (TRD) is defined by the European Medicines Agency as a lack of clinically meaningful improvement after treatment, with at least two different antidepressants.
Giuseppe Maina   +61 more
semanticscholar   +1 more source

Treatment-resistant depression and its diagnosis and treatment

open access: yesSichuan jingshen weisheng, 2022
The aim of this study is to explore the diagnostic strategies and options for treatment-resistant depression (TRD). Despite the well-established efficacy of antidepressants, 20%~30% of depressive patients in the clinic fail to respond or respond poorly ...
Hu Shaohua
doaj   +1 more source

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression

open access: yesFrontiers in Pharmacology, 2018
Introduction: It is a basic principle of the “psychedelic” treatment model that the quality of the acute experience mediates long-term improvements in mental health.
Leor Roseman, D. Nutt, R. Carhart-Harris
semanticscholar   +1 more source

Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial

open access: yesNeuropsychopharmacology, 2021
This study aimed to investigate the role of baseline levels of peripheral inflammation when testing the efficacy of antidepressant augmentation with minocycline in patients with treatment-resistant depression.
M. Nettis   +15 more
semanticscholar   +1 more source

Metyrapone in treatment-resistant depression [PDF]

open access: yesTherapeutic Advances in Psychopharmacology, 2012
Depression affects a significant proportion of the population, with 1-year and lifetime prevalence of 3–5% and 10–30% respectively. Full remission is achieved in only a third of patients following treatment with first-line antidepressant. There is a need for novel treatments for treatment-resistant depression (TRD).
Paul David, Sigalas   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy